Immunwork, Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Investigate the Safety and Tolerability of TE-8105 in Overweight/Obese Participants Without Diabetes (NCT06471530) | Immunwork, Inc. | 2024-07-09 |
| A Phase 1 Study of TE-8214 Solution in Healthy Volunteers (NCT06372652) | Immunwork, Inc. | 2024-06-18 |
Track Immunwork, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.